do glp-1 agonists have cardiovascular benefit Receptor in Heart Failure Management Can one drug do it

Link Henshaw D, Sparler N, Talbott A, et al

Age-associated cholesterol reduction triggers brain insulin resistance by facilitating ligand-independent receptor activation and pathway desensitization

Pati, S., Irfan, W., Jameel, A., Ahmed, S., & Shahid, R

doi: 10.1089/dia.2011.0050 [DOI] [PMC free article] [PubMed] [Google Scholar] 63.Jacobsen LV, Flint A, Olsen AK, Ingwersen SH

DXR, doxorubicin

If patients have a severe obesity-related complication including but not limited to hypertension, type 2 diabetes, CVD, dyslipidemia and a BMI of 27 mg/kg 2 or greater, then concurrent initiation of weight-loss medication with lifestyle interventions can be considered, according to the guideline